Wed, Jul 30, 2014, 9:03 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

StemCells Inc. Message Board

  • stem_cur stem_cur May 13, 2013 1:11 PM Flag

    ... "MARKETS: Position Yourself For Big Returns In The Stem Cell Space: Jason Kolbert"

    http://seekingalpha.com/article/1428851

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Go to the lifesciencesreport site and read the article.........here is an excerpt......

      TLSR: We saw StemCells Inc. (STEM:NASDAQ) CEO Martin McGlynn at the RegenMed conference talking about his company, which is dealing with spinal cord injury and lysosomal storage disorders with its HuCNS-SC adult stem cells of embryonic origin. Do you follow this company?

      JK: I do. I admire the work that Martin McGlynn has done and, specifically, the investigators at the company—Dr. Stephen Huhn and Dr. Ann Tsukamoto. This company operates at the next level of cell therapy. When I talk about mesenchymal cells and the trophic effects, it's exciting. But when I talk about potentially pluripotent cells and the ability for cells to remyelinate a demyelinating disorder like Batten disease, or to impact dry macular degeneration, or to impact the outcome in spinal paralysis. . .we're talking about the next level of science.

      While it's been painstakingly meticulous, with the science and evolution of the field taking a long time, the way that StemCells is going about its clinical trials and developing its product and its cell line has been brilliant. I think it is a true leader in the field. When we look central nervous system (CNS) disorders, we should look at companies like StemCells—and the way it is accomplishing its science—as the right way to do things.

      TLSR: As you are aware, the StemCells' scientific model is different from other companies, where cells are used in a drug-like model for their paracrine effects. StemCells has shown, on autopsy, durable engraftment of the human neurons that have been implanted in the brains of children with lysosomal storage disorders. It is very interesting work.

      JK: That's exactly right. And it's a very different business model as well. If you're paralyzed and you've lost all sensation, you could potentially regain some sensation

      Sentiment: Strong Buy

      • 1 Reply to stem_cur
      • ...continued......

        or maybe even regain some control (bladder control, for example) if treated with a StemCells product. That would have a huge impact on a patient's quality of life. This company is doing pioneering work.

        Investors will see a lot of breakthroughs from companies like StemCells Inc. I don't follow Advanced Cell Technology Inc. (ACTC:OTCBB), but it is doing interesting work in dry age-related macular degeneration. We recently published a very comprehensive CNS overview report in the amyotrophic lateral sclerosis space (Lou Gehrig's disease), and on the companies working to develop therapies for these patients. It is going to be an exciting couple of years as these companies start to show efficacy and proof of concept in CNS disorders.

        Sentiment: Strong Buy

    • The best among STEM companies!
      Accumulate and hold!

      Sentiment: Strong Buy

    • Due diligence

      Sentiment: Strong Buy

    • Accumulate and hold!
      Do your own research!

      Sentiment: Strong Buy

    • Accumulate and hold!
      Do your own research!

      Sentiment: Strong Buy

    • Due diligence

      Sentiment: Strong Buy

 
STEM
1.72+0.02(+1.18%)Jul 30 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
El Pollo Loco Holdings, Inc.
NasdaqGSWed, Jul 30, 2014 4:00 PM EDT
Yelp, Inc.
NYSEWed, Jul 30, 2014 4:00 PM EDT